Artemis Investment Management LLP increased its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 4.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 98,866 shares of the company’s stock after buying an additional 4,504 shares during the quarter. Artemis Investment Management LLP owned about 0.16% of Molina Healthcare worth $10,576,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Hexavest Inc. purchased a new stake in Molina Healthcare in the third quarter valued at $194,000. Centric Wealth Management boosted its holdings in Molina Healthcare by 6.2% in the third quarter. Centric Wealth Management now owns 6,694 shares of the company’s stock valued at $737,000 after purchasing an additional 389 shares during the last quarter. State of Alaska Department of Revenue boosted its holdings in Molina Healthcare by 46.3% in the third quarter. State of Alaska Department of Revenue now owns 11,956 shares of the company’s stock valued at $1,311,000 after purchasing an additional 3,783 shares during the last quarter. Boston Partners purchased a new stake in Molina Healthcare in the second quarter valued at $82,898,000. Finally, BlackRock Inc. boosted its holdings in Molina Healthcare by 0.4% in the second quarter. BlackRock Inc. now owns 5,752,811 shares of the company’s stock valued at $823,458,000 after purchasing an additional 22,368 shares during the last quarter. 96.76% of the stock is currently owned by hedge funds and other institutional investors.
MOH stock opened at $113.39 on Friday. The company’s 50-day simple moving average is $118.08 and its 200-day simple moving average is $132.47. The company has a quick ratio of 1.73, a current ratio of 1.73 and a debt-to-equity ratio of 0.85. Molina Healthcare, Inc. has a 52-week low of $105.28 and a 52-week high of $159.00. The firm has a market cap of $7.08 billion, a P/E ratio of 10.23, a PEG ratio of 1.00 and a beta of 1.14.
In other news, Director Ronna Romney sold 375 shares of the stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $131.63, for a total transaction of $49,361.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.77% of the company’s stock.
Several equities research analysts have commented on MOH shares. Stephens set a $150.00 price target on shares of Molina Healthcare and gave the company a “hold” rating in a report on Wednesday, August 7th. ValuEngine raised shares of Molina Healthcare from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Deutsche Bank started coverage on shares of Molina Healthcare in a report on Thursday, September 12th. They issued a “buy” rating and a $145.00 price target on the stock. Bank of America reaffirmed an “underperform” rating and issued a $140.00 price target (up from $132.00) on shares of Molina Healthcare in a report on Wednesday, July 31st. Finally, Morgan Stanley lowered their price target on shares of Molina Healthcare from $184.00 to $172.00 and set an “overweight” rating on the stock in a report on Friday, August 23rd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $160.70.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Further Reading: How to identify percentage decliners
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.